nse cipla bse sensex constituent cnx nifty constituent industry pharmaceuticals founded 1935 founder dr. k. a. hamied headquarters mumbai maharashtra india area served worldwide key people y. k. hamied chairman umang vohra ceo products pharmaceuticals and diagnostics revenue 104.83 billion us 1.6 billion 2013 14 1 operating income 18.80 billion us 280 million 2012 13 1 net income 13.89 billion us 210 million 2013 14 1 total assets 109.68 billion us 1.6 billion 2013 14 1 total equity 100.91 billion us 1.5 billion 2013 14 1 number of employees 22 036 2 website www.cipla.com cipla limited is an indian multinational pharmaceutical and biotechnology company headquartered in mumbai india . 3 4 5 6 as of 17 september 2014 its market capitalisation was 517 billion us 7.7 billion making it india s 42nd largest publicly traded company by market value . 7 8 9 contents 1 history 2 products and services 3 operations 4 listings and shareholding 5 awards and recognitions 6 criticism 6.1 emergency contraception 6.2 generic drugs 7 see also 8 references 9 external links history edit it was founded by dr. khwaja abdul hamied as the chemical industrial & pharmaceutical laboratories in 1935 in mumbai . 10 11 the name of the company was changed to cipla limited on 20 july 1984 . 11 in the year 1985 us fda approved the company s bulk drug manufacturing facilities . 12 led by the founder s son yusuf hamied a cambridge educated chemist the company became a global icon for its role in defying western multinational pharmaceutical companies in order to provide generic aids and other drugs to treat poor people in the developing world . 13 in 1994 cipla launched deferiprone the world s first oral iron chelator . 10 in 2001 cipla offered medicines antiretrovirals for hiv treatment at a fractional cost less than 350 per year per patient . 14 in 2013 cipla acquired the south african company cipla medpro kept it as a subsidiary and changed its name to cipla medpro south africa limited . 15 16 at the time of the acquisition cipla medpro had been a distribution partner for cipla and was south africa s third biggest pharmaceutical company . 15 the company had been founded in 2002 and was known as enaleni pharmaceuticals ltd. 17 in 2005 enaleni bought all the shares of cipla medpro which had been a joint venture between cipla and medpro pharmaceuticals a south african generics company 18 and in 2008 it changed its name to to cipla medpro . 19 products and services edit cipla sells active pharmaceutical ingredients to other manufacturers as well as pharmaceutical and personal care products 20 including escitalopram anti depressant lamivudine and fluticasone propionate . 2 they are the world s largest manufacturer of antiretroviral drugs 20 21 operations edit cipla has 34 manufacturing units in 8 locations across india and has presence in 100 countries . 22 23 exports accounted for 48 % 49.48 billion us 740 million of its revenue for fy 2013 14 . 1 cipla spent inr 517 cr . 5.4 % of revenue in fy 2013 14 on r & d activities . 1 the primary focus areas for r & d were development of new formulations drug delivery systems and apis active pharmaceutical ingredients . cipla also cooperates with other enterprises in areas such as consulting commissioning engineering project appraisal quality control know how transfer support and plant supply . as on 31 march 2013 the company had 22 036 employees out of which 2 455 were women 7.30 % and 23 were employees with disabilities 0.1 % . 2 during the fy 2013 14 the company incurred 12.85 billion us 190 million on employee benefit expenses . 1 listings and shareholding edit the equity shares of cipla are listed on the bombay stock exchange 24 where it is a constituent of the bse sensex index 25 and the national stock exchange of india 26 where it is a constituent of the cnx nifty . 27 its global depository receipts gdrs are listed on the luxembourg stock exchange . 1 as on 30 september 2014 the promoter group dr. y. k. hamied and his family held around 36.80 % equity shares in cipla . around 148 000 individual shareholders held approx . 18.67 % of its shares . 28 lic is the largest non promoter shareholder with approx . 6.45 % shareholding in the company by the end of september 2013 . 29 shareholders as on 31 march 2014 shareholding 28 promoter group 36.80 % foreign institutional investors fii 23.32 % individual shareholders 19.00 % insurance companies 06.59 % private corporate bodies 04.68 % mutual funds and uti 04.43 % nri fcb others 03.46 % gdrs 01.10 % total 100.0 % awards and recognitions edit in 2012 cipla received the thomson reuters india innovation award . 30 cipla won dun & bradstreet american express corporate awards for 2006 . 31 in 2005 forbes included cipla in the 200 best under a billion list of best small asian companies . 32 in 1980 cipla won chemexcil award for excellence for exports . 12 cipla stood third in the india s most reputed brands pharmaceutical list 33 in a study conducted by bluebytes 34 a leading media analytics firm in association with tra research 35 a brand insights organization both a part of the comniscient group . criticism edit emergency contraception edit in august 2007 cipla launched an emergency contraception pill sold over the counter 36 which was controversial with regard to its marketing its being available without a prescription and the amount of drug in the pill . 37 38 generic drugs edit in the late 1960s cipla began manufacturing a new patented drug propranolol and when the drug s patent holder ici protested to the indian government the ceo of cipla successfully lobbied the government of indira gandhi to change india s patent laws to eliminate patents that directly covered drugs and instead to allow only patents that covered methods to make drugs . 39 this change made propranolol and other patented drugs generic and led to criticism of both india s patent laws and cipla . 40 india reinstated patents on drugs in 2005 . 39 see also edit pharmaceutical industry in india generic drug list of pharmaceutical companies companies portal pharmacy and pharmacology portal references edit a b c d e f g h i annual report 2013 14 pdf . cipla . 22 august 2014 . retrieved 17 september 2014 . a b c business responsibility report 2013 14 pdf . cipla . 15 july 2014 . retrieved 17 september 2014 . cipla to buy 51 % in yemen distribution company business line cipla invests 1.5 million in chase pharma business line cipla gets 345 million rand south african contract business line cambridge varsity honour for cipla chief business line top companies by market capitalisation . money control . 17 september 2014 . retrieved 17 september 2014 . cipla to sell msd s hiv drug in india business line cipla hetero to roll out biosimilar drug business line a b about us history . cipla limited . retrieved 3 november 2013 . a b company history cipla ltd. . economic times . retrieved 3 november 2013 . a b company profile cipla limited . indiainfoline.com . retrieved 3 november 2013 . interview with yusuf hamied . creating emerging markets . harvard business school . indian drug company offers cheap aids drugs . usa today . 19 june 2001 . retrieved 3 november 2013 . a b jawani lohit july 16 2013 . cipla completes acquisition of south africa s cipla medpro . vc circle . delists from jse . business day live . 2013 . retrieved 13 july 2013 . enaleni pharmaceuticals limited prospectus 2005 . morningstar . retrieved september 8 2016 . avafia tenu ; berger jonathan ; hartzenberg trudi 2006 . the ability of select sub saharan african countries to utilise trips flexibilities and competition law to ensure a sustainable supply of essential medicines a study of producing and importing countries pdf . who . kahn tamar september 10 2008 . south africa enaleni takes name of its unit cipla medpro . all africa . a b cipla ltd cipla natl india . business week . retrieved 7 november 2013 . aids healthcare foundation campaign challenges cipla over drug pricing in india . pr newswire . 8 august 2007 . retrieved 4 november 2013 . link title cipla limited revenue and financial data . cipla . retrieved 9 september 2016 . cipla in the pink of health . business standard . 25 september 2013 . retrieved 5 november 2013 . cipla limited . bseindia.com . retrieved 2 november 2013 . scripwise weightages in s & p bse sensex . bse india . retrieved 2 november 2013 . ntpc limited . nse india . retrieved 2 november 2013 . download list of cnx nifty stocks . csv . nse india . retrieved 2 november 2013 . a b shareholding pattern as on 30th september 2013 pdf . cipla limited . retrieved 2 november 2013 . cipla shareholding belonging to the category public and holding more than 1 % of the total no.of shares . moneycontrol.com . 30 september 2013 . retrieved 4 november 2013 . dbt cipla get thomson reuters india innovation awards pharmaceutical sector award . dun & bradstreet . 10 september 2006 . retrieved 3 november 2013 . asian paints cipla in forbes list . economic times . 17 november 2005 . retrieved 3 november 2013 . http economictimes.indiatimes.com pharma lupinsun pharma and cipla amongst tops most reputed pharma brand list articleshow 53742154 . cms http www.bluebytes.info http www.trustadvisory.info cipla rises on morning after pill . hindustan times . 5 october 2007 . retrieved 3 november 2013 . cipla launches i pill . financial express . retrieved 3 november 2013 . i pill by cipla draws criticism from experts . financial express . 27 october 2007 . retrieved 3 november 2013 . a b the treasure of mumbai . wired magazine . december 2006 . retrieved 4 november 2013 . indian generic drug maker targets sad americans . biohealthinvestor.com . 3 january 2007 . retrieved 4 november 2013 . external links edit official website v t e major indian companies economy of india list of companies of india automotive ashok leyland bajaj auto eicher motors hero motocorp hindustan motors mahindra & mahindra tafe tata motors tvs aerospace and defence bharat electronics drdo hal ordnance factories conglomerates aditya birla adani avantha bajaj bharti essar essel gmr godrej gvk hinduja itc jaypee jindal kirloskar jsw l & t lanco mahindra muthoot murugappa ramoji reliance adag reliance rpg sahara shapoorji pallonji sun tata tvs torrent ub videocon wadia civil aviation air india indigo jet airways consumer goods and retail britannia industries dabur flipkart future group godrej consumer hindustan unilever itc nirma reliance retail tata global beverages energy and natural resources bharat petroleum cairn india chennai petroleum coal india gail essar oil hindustan petroleum indian oil corporation l & t national aluminum nhpc nmdc nlc ntpc oil india ongc power finance power grid rinl reliance infrastructure recl sci sesa goa suzlon energy tata power finance andhra bank axis bank bank of baroda bank of india canara bank central bank of india hdfc bank icici bank idbi bank ing vysya bank jammu & kashmir bank kotak mahindra bank lic mudra bank muthoot finance ltd punjab national bank sbi tamilnad mercantile bank union bank of india yes bank healthcare pharmaceutical & biotech aurobindo pharma cadila healthcare cipla glenmark pharmaceuticals dr. reddy s idpl iil lupin sun pharmaceutical manufacturing and heavy industries acc ambuja apollo tyres bengal chemicals and pharmaceuticals bhushan bhel dlf gammon india havells hcc hindalco india cements jindal steel jsw mrf sail tata steel ultratech information technology hcl technologies infosys tata consultancy services tech mahindra wipro media sun group the times group living media telecommunications aircel airtel bsnl idea cellular micromax mobile mtnl reliance